These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19085958)

  • 1. The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis.
    Shalev I; Wong KM; Foerster K; Zhu Y; Chan C; Maknojia A; Zhang J; Ma XZ; Yang XC; Gao JF; Liu H; Selzner N; Clark DA; Adeyi O; Phillips MJ; Gorczynski RR; Grant D; McGilvray I; Levy G
    Hepatology; 2009 Feb; 49(2):387-97. PubMed ID: 19085958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3.
    Yang C; Chen Y; Guo G; Li H; Cao D; Xu H; Guo S; Fei L; Yan W; Ning Q; Zheng L; Wu Y
    Gut; 2013 Aug; 62(8):1204-13. PubMed ID: 22637698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C5aR, TNF-α, and FGL2 contribute to coagulation and complement activation in virus-induced fulminant hepatitis.
    Liu J; Tan Y; Zhang J; Zou L; Deng G; Xu X; Wang F; Ma Z; Zhang J; Zhao T; Liu Y; Li Y; Zhu B; Guo B
    J Hepatol; 2015 Feb; 62(2):354-62. PubMed ID: 25200905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression.
    Yu H; Liu Y; Wang H; Wan X; Huang J; Yan W; Xi D; Luo X; Shen G; Ning Q
    Front Immunol; 2018; 9():2935. PubMed ID: 30619295
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
    Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA
    J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression.
    Xu GL; Chen J; Yang F; Li GQ; Zheng LX; Wu YZ
    Hepatology; 2014 Jul; 60(1):114-24. PubMed ID: 24604562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A disparate subset of double-negative T cells contributes to the outcome of murine fulminant viral hepatitis via effector molecule fibrinogen-like protein 2.
    Wu D; Wang H; Yan W; Chen T; Wang M; Han M; Wu Z; Wang X; Ai G; Xi D; Shen G; Luo X; Ning Q
    Immunol Res; 2016 Apr; 64(2):518-30. PubMed ID: 26482053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of virus-specific CD4+ cytotoxic T cells in recovery from mouse hepatitis virus infection.
    Wijburg OL; Heemskerk MH; Sanders A; Boog CJ; Van Rooijen N
    Immunology; 1996 Jan; 87(1):34-41. PubMed ID: 8666433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-33 protects murine viral fulminant hepatitis by targeting coagulation hallmark protein FGL2/fibroleukin expression.
    Yu H; Liu Y; Huang J; Wang H; Yan W; Xi D; Shen G; Luo X; Ning Q
    Mol Immunol; 2017 Jul; 87():171-179. PubMed ID: 28494352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [KCTD9, a novel potassium channel related gene, was highly expressed in hepatic NK cells and T cells of fulminant hepatitis mice induced by MHV-3].
    Zhou YY; Zou Y; Chen T; Wang HW; Han MF; Pi B; Yan WM; Xi D; Huang JQ; Luo XP; Ning Q
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):833-7. PubMed ID: 22433305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B.
    Zhu CL; Yan WM; Zhu F; Zhu YF; Xi D; Tian DY; Levy G; Luo XP; Ning Q
    World J Gastroenterol; 2005 Nov; 11(44):6936-40. PubMed ID: 16437596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the fgl2 and its protein product (prothrombinase) in tissues during murine hepatitis virus strain-3 (MHV-3) infection.
    Ding JW; Ning Q; Liu MF; Lai A; Peltekian K; Fung L; Holloway C; Yeger H; Phillips MJ; Levy GA
    Adv Exp Med Biol; 1998; 440():609-18. PubMed ID: 9782336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+ CD25+ Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice.
    Wang J; Vuitton DA; Müller N; Hemphill A; Spiliotis M; Blagosklonov O; Grandgirard D; Leib SL; Shalev I; Levy G; Lu X; Lin R; Wen H; Gottstein B
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003755. PubMed ID: 25955764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The functions of liver natural killer cells in murine fulminant hepatitis induced by murine hepatitis virus strain 3].
    Zou Y; Chen T; Wang HW; Yan WM; Luo XP; Ning Q
    Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):660-4. PubMed ID: 18822205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Th1 cell line (3E9.1) from resistant A/J mice inhibits induction of macrophage procoagulant activity in vitro and protects against MHV-3 mortality in vivo.
    Chung S; Gorczynski R; Cruz B; Fingerote R; Skamene E; Perlman S; Leibowitz J; Fung L; Flowers M; Levy G
    Immunology; 1994 Nov; 83(3):353-61. PubMed ID: 7835959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.
    Marsden PA; Ning Q; Fung LS; Luo X; Chen Y; Mendicino M; Ghanekar A; Scott JA; Miller T; Chan CW; Chan MW; He W; Gorczynski RM; Grant DR; Clark DA; Phillips MJ; Levy GA
    J Clin Invest; 2003 Jul; 112(1):58-66. PubMed ID: 12840059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of CD4-CD8- T cells in the murine hepatitis virus type 3 induced chronic viral hepatitis].
    Wang XJ; Yan WM; Zhang JG; Wang HW; Zou Y; Luo XP; Ning Q
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):180-3. PubMed ID: 19335979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
    Liu MF; Ning Q; Pope M; Mosmann T; Leibowitz J; Ding JW; Fung LS; Rotstein O; Gorczynski R; Levy GA
    Adv Exp Med Biol; 1998; 440():415-23. PubMed ID: 9782309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice.
    Zhu C; Sun Y; Luo X; Yan W; Xi D; Ning Q
    Hum Gene Ther; 2006 Jun; 17(6):589-600. PubMed ID: 16776568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.
    Fingerote RJ; Cruz BM; Gorczynski RM; Fung LS; Hubbell HR; Suhadolnik RJ; Levy GA
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():373-80. PubMed ID: 7844557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.